MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ajco.70104

Медицинская библиотека · Asia-Pacific journal of clinical oncology · 2026

Impact of Pre-Transplant Depth of Response on Outcomes in Patients With Multiple Myeloma: A Report on Behalf of Pakistan Blood and Marrow Transplant Group.

Ali Natasha, Ahmed Danyal, Iftikhar Raheel, Iftikhar Ayesha, Anwar Nida, Bokhari Syed Waqas, Zaidi Uzma, Ahmad Usman, Sarwar Shahzad, Humayun Saima, Khan Maryam, Ahsan Bushra, Khan Farrukh Ali, Jamal Aisha, Qureshi Fawad, Moosajee Munira, Zahur Umar, Borhany Munira, Adil Salman Naseem, Mir Muhammad Ayaz

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Depth of response prior to autologous stem cell transplantation (ASCT) has been associated with improved progression-free survival (PFS) in multiple myeloma (MM). This study aimed to evaluate the impact of pre-transplant response depth on post-transplant outcomes in patients with multiple myeloma.

SUBJECTS AND

METHODS

This retrospective multicenter analysis, conducted by the Pakistan Blood and Marrow Transplant group, included 223 MM patients treated over 18 years across six centers. Pre-transplant responses were classified using International Myeloma Working Group criteria. Overall survival (OS) and disease-free survival (DFS) were estimated using Kaplan-Meier methods.

RESULTS

The cohort had a mean age of 49 years, with 70.4% males. Back pain (56%) and pathological fractures (15%) were common presenting features. Anemia and renal impairment were noted in 45% and 26%, respectively. The predominant paraprotein subtype was IgG kappa (31%). ISS staging revealed that 33.3% of patients had stage I, 27.4% stage II, and 37.6% stage III disease. Induction therapy included RVd in 42% and CyBorD in 41% of patients. Post-induction responses showed complete stringent response (sCR) in 7.4%, complete response (CR) in 22%, very good partial response (VGPR) in 19%, and partial response (PR) in 18%. Age less than 50 years, favorable induction response, and achieving VGPR or more before ASCT were significantly associated with improved outcomes. At the time of transplant, 58.3% had sCR/CR and 20.2% had VGPR. Median OS was 72.4% at a median of 72 months, while DFS was 57% at a median of 47 months. Patients with sCR/CR prior to ASCT had significantly better OS and DFS.

CONCLUSION

In resource-constrained settings, achieving a deeper response before ASCT is associated with superior survival outcomes in MM. Optimizing induction to attain at least VGPR may enhance the benefit of transplantation.

Для цитирования: Ali Natasha, Ahmed Danyal, Iftikhar Raheel, Iftikhar Ayesha, Anwar Nida, Bokhari Syed Waqas, Zaidi Uzma, Ahmad Usman, Sarwar Shahzad, Humayun Saima, Khan Maryam, Ahsan Bushra, Khan Farrukh Ali, Jamal Aisha, Qureshi Fawad, Moosajee Munira, Zahur Umar, Borhany Munira, Adil Salman Naseem, Mir Muhammad Ayaz. Impact of Pre-Transplant Depth of Response on Outcomes in Patients With Multiple Myeloma: A Report on Behalf of Pakistan Blood and Marrow Transplant Group.. Asia-Pacific journal of clinical oncology. 2026. DOI: 10.1111/ajco.70104.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.